177 related articles for article (PubMed ID: 3929876)
41. Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound.
Hakkarainen H; Quiding H; Stockman O
J Clin Pharmacol; 1980 Oct; 20(10):590-5. PubMed ID: 7440766
[TBL] [Abstract][Full Text] [Related]
42. Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine.
Dahlöf C
Cephalalgia; 1993 Jun; 13(3):166-71. PubMed ID: 8358774
[TBL] [Abstract][Full Text] [Related]
43. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
Frenken CW; Nuijten ST
Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
[TBL] [Abstract][Full Text] [Related]
44. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
[TBL] [Abstract][Full Text] [Related]
45. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study.
van de Ven LL; Franke CL; Koehler PJ
Cephalalgia; 1997 Aug; 17(5):596-9. PubMed ID: 9251876
[TBL] [Abstract][Full Text] [Related]
46. Feverfew. Bachelor's buttons, Featherfew (Tanacetum parthenium L. aka Chrysanthemum parthenium L. aka Pyrethrum parthenium L.).
Goodyear-Smith F
J Prim Health Care; 2010 Dec; 2(4):337. PubMed ID: 21125077
[No Abstract] [Full Text] [Related]
47. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Klapper J
Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
[TBL] [Abstract][Full Text] [Related]
48. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
49. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
50. Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species.
Hausen BM; Osmundsen PE
Acta Derm Venereol; 1983; 63(4):308-14. PubMed ID: 6195862
[TBL] [Abstract][Full Text] [Related]
51. Feverfew (Tanacetum parthenium L.): A systematic review.
Pareek A; Suthar M; Rathore GS; Bansal V
Pharmacogn Rev; 2011 Jan; 5(9):103-10. PubMed ID: 22096324
[TBL] [Abstract][Full Text] [Related]
52. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study.
Schrader H; Stovner LJ; Helde G; Sand T; Bovim G
BMJ; 2001 Jan; 322(7277):19-22. PubMed ID: 11141144
[TBL] [Abstract][Full Text] [Related]
53. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
54. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
55. Feverfew and vascular smooth muscle: extracts from fresh and dried plants show opposing pharmacological profiles, dependent upon sesquiterpene lactone content.
Barsby RW; Salan U; Knight DW; Hoult JR
Planta Med; 1993 Feb; 59(1):20-5. PubMed ID: 8441776
[TBL] [Abstract][Full Text] [Related]
56. Diclofenac-potassium in migraine: a review.
McNeely W; Goa KL
Drugs; 1999 Jun; 57(6):991-1003. PubMed ID: 10400409
[TBL] [Abstract][Full Text] [Related]
57. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
[TBL] [Abstract][Full Text] [Related]
58. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
59. Three newly identified lipophilic flavonoids in Tanacetum parthenium supercritical fluid extract penetrating the Blood-Brain Barrier.
Végh K; Riethmüller E; Hosszú L; Darcsi A; Müller J; Alberti Á; Tóth A; Béni S; Könczöl Á; Balogh GT; Kéry Á
J Pharm Biomed Anal; 2018 Feb; 149():488-493. PubMed ID: 29182998
[TBL] [Abstract][Full Text] [Related]
60. Herbal therapy for migraine. An unconventional approach.
Diamond S
Postgrad Med; 1987 Jul; 82(1):197-8. PubMed ID: 3601836
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
